Torii Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3635800000
JPY
6,350.00
20 (0.32%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
16,696.00
14,683.00
17,093.00
15,024.00
14,858.00
13,451.00
15,506.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
16,696.00
14,683.00
17,093.00
15,024.00
14,858.00
13,451.00
15,506.00
Raw Material Cost
9,555.00
8,059.00
9,786.00
8,232.00
8,214.00
7,487.00
8,749.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
4,388.00
4,243.00
4,541.00
4,440.00
4,055.00
4,048.00
4,253.00
Other Expenses
130.50
67.70
62.80
83.30
83.10
53.20
67.90
Total Expenditure (Excl Depreciation)
15,248.00
12,979.00
14,955.00
13,505.00
13,100.00
12,067.00
13,681.00
Operating Profit (PBDIT) excl Other Income
1448
1704
2138
1519
1758
1384
1825
Other Income
159.00
151.00
-81.00
172.00
59.00
-223.00
456.00
Operating Profit (PBDIT)
1,707.00
1,953.00
2,166.00
1,790.00
1,911.00
1,267.00
2,402.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
7,141.00
6,624.00
7,307.00
6,792.00
6,644.00
5,964.00
6,757.00
Depreciation
100.00
98.00
109.00
99.00
94.00
106.00
121.00
Profit Before Tax
1,608.00
1,854.00
2,057.00
1,692.00
1,816.00
1,160.00
2,281.00
Tax
411.00
462.00
539.00
388.00
474.00
281.00
529.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,197.00
1,391.00
1,517.00
1,304.00
1,343.00
878.00
1,751.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,197.00
1,391.00
1,517.00
1,304.00
1,343.00
878.00
1,751.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,197.00
1,391.00
1,517.00
1,304.00
1,343.00
878.00
1,751.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,22,476.00
1,21,203.00
1,21,533.00
1,20,087.00
1,20,443.00
1,19,041.00
1,20,134.00
Earnings per share (EPS)
42.58
49.48
53.96
46.39
47.78
31.24
62.3
Diluted Earnings per share
42.58
49.48
53.96
46.39
47.78
31.24
62.3
Operating Profit Margin (Excl OI)
8.67%
11.61%
12.51%
10.11%
11.83%
10.29%
11.77%
Gross Profit Margin
10.23%
13.29%
12.67%
11.92%
12.86%
9.41%
15.49%
PAT Margin
7.17%
9.47%
8.87%
8.68%
9.04%
6.53%
11.29%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 12.37% vs 6.98% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is -10.87% vs -2.26% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is -16.41% vs -10.14% in Jun 2024

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024

Compare Quarterly Results Of Torii Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
16,696.00
19,489.79
-2,793.79
-14.33%
Other Operating Income
0.00
0.00
0.00
Total Operating income
16,696.00
19,489.79
-2,793.79
-14.33%
Raw Material Cost
9,555.00
5,578.66
3,976.34
71.28%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
121.87
-121.87
-100.00%
Selling and Distribution Expenses
4,388.00
12,390.59
-8,002.59
-64.59%
Other Expenses
130.50
-12.19
142.69
1,170.55%
Total Expenditure (Excl Depreciation)
15,248.00
17,969.25
-2,721.25
-15.14%
Operating Profit (PBDIT) excl Other Income
1,448.00
1,520.54
-72.54
-4.77%
Other Income
159.00
260.93
-101.93
-39.06%
Operating Profit (PBDIT)
1,707.00
3,530.50
-1,823.50
-51.65%
Interest
0.00
121.87
-121.87
-100.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
7,141.00
13,911.13
-6,770.13
-48.67%
Depreciation
100.00
1,749.04
-1,649.04
-94.28%
Profit Before Tax
1,608.00
1,659.60
-51.60
-3.11%
Tax
411.00
624.62
-213.62
-34.20%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,197.00
1,090.75
106.25
9.74%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,197.00
1,090.75
106.25
9.74%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
-55.77
55.77
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,197.00
1,034.98
162.02
15.65%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,22,476.00
87,437.24
35,038.76
40.07%
Earnings per share (EPS)
42.58
24.75
17.83
72.04%
Diluted Earnings per share
42.58
24.75
17.83
72.04%
Operating Profit Margin (Excl OI)
8.67%
7.80%
0.00
0.87%
Gross Profit Margin
10.23%
17.49%
0.00
-7.26%
PAT Margin
7.17%
5.60%
0.00
1.57%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,669.60 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 13.71% vs -14.10% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 12.37% vs 6.98% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 119.70 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -13.95% vs -8.31% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -10.87% vs -2.26% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 154.80 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -14.10% vs -19.80% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -16.41% vs -10.14% in Jun 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.67%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024